chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After getting the booster shot at about 30 pm and 4 to 5 hours later I started feeling nauseous and chills. And I couldn't sleep that night because of very bad chills. I had chills the next day also. And the night of the shot my arm started getting sore and swelling and has turned bright pink and started itching. i still have the chills and the issues with the arm.
Case number PHEH2014US025014, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 33 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Arm is red, itchy, swollen, patient stated that it feels warm. Patient received shot on 06/08/18 and presented to the pharmacy on 06/13/18. Recommends the patient take some BENADRYL to help with symptoms and contact the doctor in the morning to be evaluated for a possible antibiotic.
Random periods of perceived increase in heart beat when sitting down.  First observed 10/25 but continued into 10/26.  Checked heart beat - was around 60 bpm which is typical resting heart beat
JOINT PAIN, CHILLS FOR 3 HOURS, FEVER, NAUSEA, FATIGUE
This is a spontaneous report from a contactable consumer. This consumer (patient) reported that a 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207) at the age of 39-years, via an unspecified route of administration in right arm on 19Mar2021 14:00 at single dose for COVID-19 immunization. Medical history was not reported. No COVID-19 prior vaccination, no other vaccine in four weeks. There were other medications in two weeks. The patient previously took zaleplon (SONOTA) and experienced allergy to it. On 23Mar2021 08:00 AM, the patient developed transverse myelitis following the first vaccination. The patient went to ER and was admitted and treated there for the following week for the condition transverse myelitis. The event result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization for 7 days, life threatening illness (immediate risk of death from the event). The patient received 5-day course of IV steroids as treatment. Outcome of the event was not recovered. The patient underwent lab tests and procedures, which included COVID-19 virus test (nasal swab) was negative on 10Apr2021.
Patient was given 0.25mcg of Moderna Bivalent Booster, patient was to be given 0.5mcg. Wrong dose was given.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of ROTATEQ orally reported lot # L033549 with expiration date of 05-JUN-2017 (dose number was not provided). The patients' concomitant medications were not reported. It was reported by the nurse, that ROTATEQ was exposed to a temperature of 34 degrees F for 12 hours. The aforementioned vaccine had never been involved in any previous temperature excursion. Data logger was stated. Furthermore, no adverse event symptoms were reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of herpes zoster (shingles), pain (painful) and diarrhea in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 025L20A and 011M20A) for COVID-19 immunization. No medical history reported. On Jan 7, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 4, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. March 2021, patient experienced herpes zoster (shingles), pain (painful) and diarrhea. The patient treated with prednisone at an unspecified dose and frequency; and acyclovir at an unspecified dose and frequency; Covarex (miconazole nitrate) at an unspecified dose and frequency and sulfamethoxazole at an unspecified dose and frequency. At the time of the report, herpes zoster (shingles), pain (painful) and diarrhea outcome: unknown. Concomitant product use not provided. Action taken with mRNA-1273 in response to the event: not applicable.
Fainted on April 9, waking to racing heart and shortness of breath. Chest pain and shortness of breath persisted. Visited Emergency Room evening of April 11. Multiple tests revealed diagnosis of pulmonary embolism. Was immediately transferred to hospital early April 12. Received blood thinning treatment and catheter operation. Discharged April 15, with prescription of Eliquis for continued blood thinning.
Took Benadryl before getting the shot at 2:30pm Allergic reaction resulting in facial and throat swelling, red welts at the back of the throat, wheezing, going unconscious and shaking all within 2 hours of receiving the vaccine  Took second Benadryl to try and calm down the reaction (no effect) Epipen was given at the advice of my physician at 6:30pm Was directed to the ER Given medication in the ER Released after 4 hours
Patient from doctor's office called the pharmacy to report that the patient had developed cellulitis, she received the vaccine on 6/9/12, the patient seeked medical attention on 6/11/12. Patient also reported that this was due to the vaccine being given in the wrong in the wrong place ie approximately 1" above the elbow. She was given an antibiotic. Patient also developed a possible shingles rash on right cheek.
Subsequent to receiving the first dose of varicella virus vaccine live the pt experienced a rash on the neck and torso. The rash was described as pimple like, red, raised with center, little bumps. One week prior to onset of rash, pt felt tired and feverish.
06Nov2023 Patient c/o her hands, thighs, legs, and feet feeling really cold.; 06Nov2023 Patient c/o her hands, thighs, legs, and feet feeling really cold.; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 73-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 23Oct2023 as dose 1, single (Lot number: HF9300) at the age of 73 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "diabetes" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "gastritis" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa; "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "known allergies: codeine", notes: known allergies: codeine; Phenergan, reaction(s): "known allergies: Phenergan", notes: known allergies: Phenergan. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 2, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 3, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 4, Unknown manufacturer), for COVID-19 immunization. The following information was reported: FEELING COLD (non-serious), PERIPHERAL COLDNESS (non-serious) all with onset 03Nov2023, outcome "recovering" and all described as "06Nov2023 Patient c/o her hands, thighs, legs, and feet feeling really cold.". Therapeutic measures were not taken as a result of feeling cold, peripheral coldness. Additional information: Patient c/o her hands, thighs, legs, and feet feeling really cold. She stated that it started on 03Nov2023 and has gotten some better today. No COVID prior vaccination. Not COVID tested post vaccination.
First 2 shots no reaction; booster shot given because she is immune suppressed due to rheumatoid arthritis on Methotrexate. She had a 105.6 temperature overnight after the booster but returning to normal temp the next day after taking ibuprofen.
Just got done with shots and became heavy in foster mom's arms; head went down, color was very pale, breathing very shallow and unresponsive. Layed down and 30 seconds later, she came around. P-68. At 18:17, P-92 and R-32. Skin still clammy at 18:35. Called PA for MD. Pt stayed around until 19:13. Foster mom visited with PA at 19:30 and took her home.
High blood pressure, high heart rate, severe body aches, dizziness, nausea, headache, fever
Pt received influenza vaccine at 9:00 arrived at ER at 14:45 stated throat feels swollen. Solumedrol 125 mg IM given at 15:05. Pt monitored for 2 hours by Physician and then DPC to home.
No adverse effects were reported; Multiple unspecified patients were vaccinated with improperly stored PROQUAD and VARIVAX; This non-valid spontaneous report was received from the office manager and refers to multiple unspecified patients of unknown age and gender. There was no information about the patients' medical history, concurrent conditions or concomitant medications.    On an multiple unspecified dates since September 2018, the patients were mostly vaccinated with doses of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot number N027000 with expiration date of 28-SEP-2019 or lot number N022979 with expiration date of  23-AUG-2019) or doses of improperly stored rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (lot number R017628 with expiration date of 18-DEC-2019 or lot number N025929 with expiration date of 18-MAR-2019) (dose and route of administration) for prophylaxis. The vaccines were stored in the range of 6 Fahrenheit degrees to 14 Fahrenheit degrees (13.9 Fahrenheit degrees) for an unknown time frame. There were previous temperature excursions, however the details were unknown. It was reported that no doses of the and varicella (oka-merck) virus vaccine live(PROQUAD) (Lot number N025929 with expiration date 18-MAR-2019) were given after it expired; however doses were given after the first and subsequent temperature excursions, dating back to an unknown date in September 2018.   Digital data logger was involved.  Follow up information has been received from the office manager on 22-APR-2019. No dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) was administered to the patient. Sterile diluent was properly stored. No adverse effects were reported. On 25-OCT-2018, the patient was vaccinated with dose of improperly stored rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (lot number N025929 with expiration date of 18-MAR-2019). The vaccine was stored in the range of 6 Fahrenheit degrees to 14 Fahrenheit degrees (13.9 Fahrenheit degrees) for 69 hours and 11 minutes (multiple excursions). No prior excursion was confirmed. Digital data logger was involved.  This case was previously considered non-valid but upon receipt of follow-up with patient identifiers, it was determined that the case is valid now.  This one of ten reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA012655: US-009507513-1904USA012656: US-009507513-1904USA012657: US-009507513-1904USA009929: US-009507513-1904USA012659: US-009507513-1904USA012660: US-009507513-1904USA012653: US-009507513-1904USA012654: US-009507513-1904USA012652:
From patient: Two weeks after the vaccine I started having pain in my left arm. The pain is severe pain that keeps me from being able to move my arm.  The pain is still current
Experienced fatigue at 09:30PM on 06OCT2021, then hot flashes, chills and 100.6F fever at 1:35AM on 07OCT2021. Headache and fatigue experienced at 8:00AM 07OCT2021. Symptoms relieved by 9:30AM on 07OCT2021.
20 minutes post immunizations pt.'s face and eyes began swelling.  Hives on chest.  Taken to ER.  Given IV fluids.  Prescribed PREDNISONE & BENADRYL.
Started having petechiae on 7/2/13. Brought in for evaluation on 7/5/13 had platelet count of 2,000.
anaphylactic reaction to the PROQUAD; Information has been received from a nurse practitioner via company representative concerning a 4 years old patient of unknown gender. The patient had history of COVID infection 3 weeks prior to event. Information about concurrent condition and concomitant medication of the patient was unknown.    On an unknown date, the patient was vaccinated with 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, route, lot# and expiration date were not reported) for prophylaxis.  On an unknown date in January 2021, the patient had an anaphylactic reaction to the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). Patient received epinephrine (EPI PEN) and was sent to the hospital. The outcome of anaphylactic reaction was recovered on an unknown date.  The event of anaphylactic reaction was considered to be related to the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD).  Upon internal review, anaphylactic reaction to vaccine was determined to be medically significant.  This is one of two reports received from the same reporter (linked case # US-009507513-2206USA002513).; Sender's Comments:  US-009507513-2206USA002513:
Normal sore arm; but the following day about 16 hours later I woke up and passed out and fell and hit my head. This is not normal behavior for me.
This is the second immunization with shingrix 50 mcG inj (IM) sng dse vl 10pk. Sore arm, fever (chills), runny nose. Happened the same as the first dose. Generally felt like I had a bad cold both times.
messing with her heart/ heart trouble; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: unknown), via an unspecified route of administration, on 17Mar2021, as single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in 2021, patient has had trouble with Pfizer's COVID-19 vaccine. Patient received the first dose on Wednesday 17Mar2021, but it was messing with her heart, patient asked that, do people with heart trouble get the vaccine. Patient was called and told she had a close episode and whether patient got a defibrillator to shock patient's heart back if it stopped. Patient was having no problems before she got the shot. Patient was going to the doctor right now. Patient got the Pfizer shot the first shot and was wondering that didn't know if a person that has heart trouble (Further clarification was unknown) probably should not get that right. Because patient's heart doctor just called to patient and patient got to go in (incomplete sentence), some type of emergency thing (clarification unknown), patient just wanted to know if the Pfizer shot related to that or you just don't know. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-NOV-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Muscle and joint pain, headache, fatigue, feeling of coming down with the flu, no fever
Pt received PENTACEL vaccine on left thigh. Entire thigh became red and swollen for 2-4 hours. Onset was several hours after vaccine administration. Symptoms resolved in 24 hours.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Jan2021 as dose 1, single (Lot number: el9265), on 23Feb2021 as dose 2, single (Lot number: en6203), on 04Oct2021 as dose number unknown (booster), single (Batch/Lot number: unknown) and on 19Feb2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Jun2022 as dose 4 (booster), single (Lot number: 059m21a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing), notes: other medical history: high blood pressure. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14Jun2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Jun2022) positive; (18Jun2022) Negative; (24Jun2022) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient did not receive other medications in two weeks. She had her last covid booster on 09Jun2022. Tested positive home test on 14Jun2022. Started taking Paxlovid that evening for treatment of COVID-19 and finished on 19Jun2022. The patient tested negative with home test on 18Jun2022. On 24Jun202, she started having symptoms and tested Positive on that day. Adverse event start date: 23Jun2022. Known allergies: No.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The patient was supposed to receive a Shingrix shot but received a Moderna vaccine.  After getting in touch with the patient, she has stated she was feeling fine and there was no adverse reaction to the vaccine at this time. Patient was understanding and will be coming in for the correct vaccine on a different day.
MMR & varicella vaccines 1/14/13 rash noted face, torso, and diaper area 1/23/13. No fever - seen in office felt to be related to measles vaccine.
Mother states has a local reddened area to left arm at injection site, this was confirmed by Dr. - no meds were administered.
On June 4, 2008 in our immunization clinic, six children received their second dose of varicella. We are assuming one of them received a ZOSTAVAX instead of VARIVAX due to the count at the end of the day. All parents of the children were reached by 06/11/2008. None of the children had any adverse reactions, even a local one at the site of the VARIVAX. Since we are not positive that one of these children received a ZOSTAVAX, we are only giving you the names and birthdays of these children as instructed by the Immunization Program, If you need more information, please contact me. I called CDC on 6/11/08. In response to this situation, there was no specific answer in the literature, but the "expert" that was consulted stated that the dose of ZOSTAVAX, if given, should be "counted". Follow-up Information: 6/4/08 Between 1-4 PM may have given Zostavax instead of Varivax. No adverse reaction.
This non-serious spontaneous case, initially received on 05-Oct-2018 reported by other non-health professional and concerns a female patient of an unspecified age. The patient's current condition included high blood pressure. On an unspecified date, the patient was administered INN Flu Vaccine Seasonal [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported]. On an unspecified date, after vaccination, the patient experienced dizziness. The reporter stated that, the event may not be related to the suspect vaccine because she has high blood pressure which can cause it. At the time of this report, the outcome of the event was not reported. Update received on 30-Oct-2018: Non-significant case correction (IRD: 05-Oct-2018): The phrase 'was unassessable' was changed to is assessed as unassessable' in the case comment. No changed were made in the narrative.
The next day at 1:00 pm I was just hit with extreme fatigue and chills.  By the time I got home from work I ached all over and could not get warm.  I had a slight fever.  By 8:00 pm I was burning up on my skin, but no fever.  I still had aches all over.  I woke up again at 11:00 pm and I was fine.  I have had covid back in October of 2020.
This spontaneous report was received from a health care worker concerning an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and drug reactions/allergies were not reported. On an unspecified date in April 2017, the patients were vaccinated with improperly stored doses of M-M-R II lot # M035935 with expiration date: 09-AUG-2018, as prophylaxis (Strength, dose and route were not reported), which experienced a temperature excursion of 12.7 Celsius degrees for 2 hours and 15 minutes. There were no previous temperature excursions reported. Data logger was involved. No symptoms were reported. The patients' concomitant therapies included properly stored sterile diluent (manufacturer unknown). This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA006461: US-009507513-1705USA014915.
4cmx4cm red,hot,circular area to PNEUMOVAX injection site fever 101.5
Patient was scheduled to get age appropriate booster shot (Pfizer).  Patient came in with family who were also getting booster shots of different types (Pfizer and Moderna).  Pharmacy Technician (trained to give immunizations) took Moderna and Pfizer shots out to give family their boosters consecutively.  In a rush, technician accidently gave patient moderna booster meant for other patient.  Technician quickly realized error and reported in.   Patient and family were notified of mistake and monitored for adverse effects of which none occured.
Approx. 2 inch red rash (sometimes itchy) at site of injection. No other reaction.
Narrative: Historical report. medical facility. Unknown clinical course. Reported medical event after receipt of seasonal influenza vaccine in 2018. Patient has allergy documented to vaccine and does not receive seasonal influenza vaccine due to this.
Red rash to face; bilateral eye pain with redness, itching, swelling, right eye swollen worse than left eye; symptoms occrured less than 24 hours after vaccines were administered; Benadryl given with no relief; seen at Urgent Care just under 48 hours after vaccines administered and instructed to continue Benadryl with prednisone and Pepcid.
pt said he felt bad, gave him water, he started weaving in the chair, then he was slurring his words, he said he was tired, eyes rolled up a few times, we kept him talking. He was shaking and having tardine dyskinesia like movements. He then said his head hurt. Stated not diabetic, has had seizures previously, and a family member tested postivie earlier in the day but he is negative.